QuantOCancer ERA Chair

The primary pillar of QuantOCancer – attracting and retaining an outstanding researcher and research manager (the “ERA Chair holder”) to incept a quantitative biomedicine research programme focused on cancer – will bridge and transform the three main research operations at CCU (Neurosciences, Physiology and Cancer and Experimental Clinical Research) and root an effective bridge between research excellence and onsite clinical practice. The second pillar of QuantOCancer will fully unlock the potential of the institute, the Lisbon region and Portugal through the implementation of an additional set of measures, geared towards: Capacity building (expansion of the research programme, advanced training opportunities); Institutional development and structural change (further exploration of the installed research and technology capacity, HR and Equity, Inclusion and Diversity strategies); Intersectoral and international partnership activities, bolstering a Responsible Research and Innovation (RRI) culture.
https://quantocancer.fchampalimaud.org/
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 810653.